The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

Every year, the race begins anew. Scientists scramble to track mutating viruses, pharmaceutical companies reformulate ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

AbbVie is paying ADARx Pharmaceuticals $335 million upfront to secure options on next-gen small interfering RNA (siRNA) ...

Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...